4547.T

Kissei Pharmaceutical Co., Ltd. | Cotação de Ações

Última atualização04/08/2025, 01:19:44

PreçoJP¥ 4.425

Variação (dia)JP¥ 20 (0.45%)▲

Min. 52 SemanasJP¥ 3.150

Máx. 52 SemanasJP¥ 4.500

Capitalização de mercado--

Endereço: 19-48, Yoshino, Matsumoto, 399-8710

Telefone: 81 2 6325 9081

Funcionários: 1.778

KISSEI PHARMACEUTICAL CO4547.T

JP¥ 4.425

+ 200,45%

04/08/2025 01:19:44

1D 7D 1M 3M 1A Tudo

Visão geral da empresa

Preço atualJP¥ 4.425

Valor de mercado--

AberturaJP¥ 4.260

Preço máximoJP¥ 4.440

Preço mínimoJP¥ 4.345

VolumeJP¥ 39 mil

Fechamento anteriorJP¥ 4.405

Kissei Pharmaceutical Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in Japan. The company offers Kalogra tablets, for the treatment of ulcerative colitis; Tabuneos capsules for the treatment of microscopic polyangiitis and granulomatous polyangiitis; Minirin Melt OD tablets; Malizeb tablets; Tavaris tablets for the treatment of chronic idiopathic thrombocytopenic purpura; Beova tablets for the treatment of overactive bladder treatment; and Darbepoetin Alfa BS injection JCR for the treatment of renal anemia. Its products in pipeline include CG0070, which is in Phase III clinical trial to treat non-muscle-invasive bladder cancer; Linzagolix, which is in Phase III clinical trial for the treatment of uterine fibroids and endometriosis; KDT-3594, which is in Phase II clinical trial to treat Parkinson's disease; KSP-0243 that is in Phase II clinical trial to treat Ulcerative colitis; and Difelikefalin, which is in Phase III clinical trial to treat uremic pruritus in dialysis patients. The company is also developing Silodosin for dysuria associated with benign prostatic hyperplasia; and Fostamatinib for tyrosine kinase inhibitor. In addition, it develops and sells protein controlled and energy supply foods; and purchases and sells related materials, as well as offers system development and information processing, construction contracting, facility and equipment management, and information gathering and development support services. Further, the company engages in the information equipment rentals; insurance agency business; manufactures and sells noodles; and undertakes construction of factories, research institutes, offices, etc., as well as computer system design and development, and cloud services. The company was formerly known as Kissei Yakuhin Kogyo Co., Ltd. and changed its name to Kissei Pharmaceutical Co., Ltd. in October 1964. The company was incorporated in 1946 and is headquartered in Matsumoto, Japan.

Ações relacionadas

Kaken Pharmaceutical Co., Ltd.

4521.T ▲13.00% | JP¥ 4.240

Sumitomo Pharma Co., Ltd.

4506.T ▲2.00% | JP¥ 571

Nippon Shinyaku Co., Ltd.

4516.T ▲25.00% | JP¥ 3.773

Shionogi & Co., Ltd.

4507.T ▼1.00% | JP¥ 2.216

Towa Pharmaceutical Co., Ltd.

4553.T ▼30.00% | JP¥ 3.025

Descubra as últimas atualizações do mercado de ações, incluindo os preços de empresas como Magazine Luiza (MGLU3) e Petrobras (PETR4)

Mantenha-se informado sobre o mercado de ações com as atualizações da brapi. Em nossa seção de notícias, fornecemos análises profundas sobre empresas líderes, como Magazine Luiza e Petrobras, auxiliando em decisões de investimento mais esclarecidas.

Assine nossa newsletter para receber atualizações gratuitas por e-mail

Mantenha-se informado assinando nossa newsletter. Receba atualizações gratuitas por e-mail, incluindo rendimentos, novidades do mercado e insights valiosos. Estamos comprometidos em fornecer informações relevantes diretamente à sua caixa de entrada.

Saiba mais sobre a brapi e nossa missão de fornecer informações confiáveis

Entenda a missão da brapi em fornecer informações estritamente informativas de fontes confiáveis. Valorizamos a transparência e a responsabilidade, incentivando investidores a buscar aconselhamento financeiro independente para decisões informadas.